Development of BET inhibitors as potential treatments for cancer: A search for structural diversity

Hill, Matthew D.; Fang, Haiquan; Tokarski, John; Fanslau, Carolynn; Haarhoff, Zuzana; Huang, Christine; Kramer, Melissa; Menard, Krista; Monereau, Laura; Morrison, John; Ranasinghe, Asoka; Shields, Eric E.; KimTye, Ching; Westhouse, Richard; Everlof, Gerry; Sheriff, Steven; Yan, Chunhong; Marsilio, Frank; Zhang, Lisa; Zvyaga, Tatyana; Lee, Francis; Gavai, Ashvinikumar V.; Degnan, Andrew P.

doi:10.1016/j.bmcl.2021.128108

Development of BET inhibitors as potential treatments for cancer: A search for structural diversity

Journal Article · 01 July 2021 · Bioorg. Med. Chem. Lett.

DOI:https://doi.org/10.1016/j.bmcl.2021.128108· OSTI ID:1847149

Hill, Matthew D.; Fang, Haiquan; Tokarski, John; Fanslau, Carolynn; Haarhoff, Zuzana; Huang, Christine; Kramer, Melissa; Menard, Krista; Monereau, Laura; Morrison, John; Ranasinghe, Asoka; Shields, Eric E.; KimTye, Ching; Westhouse, Richard; Everlof, Gerry; Sheriff, Steven; Yan, Chunhong; Marsilio, Frank; Zhang, Lisa; Zvyaga, Tatyana more »

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY

OSTI ID:: 1847149

Journal Information:: Bioorg. Med. Chem. Lett., Vol. 44

Country of Publication:: United States

Language:: ENGLISH

References (17)

Strategies to Inhibit Myc and Their Clinical Applicability Whitfield, Jonathan R.; Beaulieu, Marie-Eve; Soucek, Laura Frontiers in Cell and Developmental Biology, Vol. 5 https://doi.org/10.3389/fcell.2017.00010	journal	February 2017
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc Delmore, Jake E.; Issa, Ghayas C.; Lemieux, Madeleine E. Cell, Vol. 146, Issue 6 https://doi.org/10.1016/j.cell.2011.08.017	journal	September 2011
Place your BETs: the therapeutic potential of bromodomains Prinjha, R. K.; Witherington, J.; Lee, K. Trends in Pharmacological Sciences, Vol. 33, Issue 3 https://doi.org/10.1016/j.tips.2011.12.002	journal	March 2012
Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery Fu, Lei-lei; Tian, Mao; Li, Xiang Oncotarget, Vol. 6, Issue 8 https://doi.org/10.18632/oncotarget.3551	journal	March 2015
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions Choudhary, C.; Kumar, C.; Gnad, F. Science, Vol. 325, Issue 5942 https://doi.org/10.1126/science.1175371	journal	July 2009
The c-MYC Oncoprotein Is a Substrate of the Acetyltransferases hGCN5/PCAF and TIP60 Patel, Jagruti H.; Du, Yanping; Ard, Penny G. Molecular and Cellular Biology, Vol. 24, Issue 24 https://doi.org/10.1128/MCB.24.24.10826-10834.2004	journal	December 2004
The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target Di Martile, Marta; Del Bufalo, Donatella; Trisciuoglio, Daniela Oncotarget, Vol. 7, Issue 34 https://doi.org/10.18632/oncotarget.10048	journal	June 2016
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers Lovén, Jakob; Hoke, Heather A.; Lin, Charles Y. Cell, Vol. 153, Issue 2 https://doi.org/10.1016/j.cell.2013.03.036	journal	April 2013
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains Mirguet, Olivier; Gosmini, Romain; Toum, Jérôme Journal of Medicinal Chemistry, Vol. 56, Issue 19 https://doi.org/10.1021/jm401088k	journal	September 2013
Discovery of N -(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1 H -pyrrolo[2,3- c ]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor McDaniel, Keith F.; Wang, Le; Soltwedel, Todd Journal of Medicinal Chemistry, Vol. 60, Issue 20 https://doi.org/10.1021/acs.jmedchem.7b00746	journal	October 2017
Bromodomains: Structure, function and pharmacology of inhibition Ferri, Elena; Petosa, Carlo; McKenna, Charles E. Biochemical Pharmacology, Vol. 106 https://doi.org/10.1016/j.bcp.2015.12.005	journal	April 2016
Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors Romero, F. Anthony; Taylor, Alexander M.; Crawford, Terry D. Journal of Medicinal Chemistry, Vol. 59, Issue 4 https://doi.org/10.1021/acs.jmedchem.5b01514	journal	April 2015
Drug Discovery Targeting Bromodomain-Containing Protein 4 Liu, Zhiqing; Wang, Pingyuan; Chen, Haiying Journal of Medicinal Chemistry, Vol. 60, Issue 11 https://doi.org/10.1021/acs.jmedchem.6b01761	journal	March 2017
Bridging solubility between drug discovery and development Di, Li; Fish, Paul V.; Mano, Takashi Drug Discovery Today, Vol. 17, Issue 9-10 https://doi.org/10.1016/j.drudis.2011.11.007	journal	May 2012
Mitigating Heterocycle Metabolism in Drug Discovery St. Jean, David J.; Fotsch, Christopher Journal of Medicinal Chemistry, Vol. 55, Issue 13 https://doi.org/10.1021/jm300343m	journal	May 2012
Applications of Fluorine in Medicinal Chemistry Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D. Journal of Medicinal Chemistry, Vol. 58, Issue 21 https://doi.org/10.1021/acs.jmedchem.5b00258	journal	July 2015
Mouse models of multiple myeloma: technologic platforms and perspectives Rossi, Marco; Botta, Cirino; Arbitrio, Mariamena Oncotarget, Vol. 9, Issue 28 https://doi.org/10.18632/oncotarget.24614	journal	April 2018

Similar Records

Lead optimization and efficacy evaluation of quinazoline-based BET family inhibitors for potential treatment of cancer and inflammatory diseases

Journal Article · 2019 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1544854

Yang, Shyh-Ming; Yoshioka, Makoto; Strovel, Jeffrey W.; +5 more

Structure-Based Development of Small Molecule PFKFB3 Inhibitors: A Framework for Potential Cancer Therapeutic Agents Targeting the Warburg Effect

Journal Article · 2012 · PLoS One · OSTI ID:1034941

Seo, Minsuh; Kim, Jeong-Do; Neau, David; +2 more

Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer

Journal Article · 2020 · Cancer Res. · OSTI ID:1833693

Slavish, P. Jake; Chi, Liying; Yun, Mi-Kyung; +27 more

Development of BET inhibitors as potential treatments for cancer: A search for structural diversity

Citation Formats

References (17)

Similar Records

Related Subjects